Why the study?
Machine learning prediction of cardiovascular disease risk is relevant to identify high-risk patients and enable timely interventions.
Does the XGBH machine learning model improve the accuracy of cardiovascular disease risk prediction compared to a baseline risk score?
Does the XGBH machine learning model improve the accuracy of cardiovascular disease risk prediction compared to a baseline risk score?
A machine learning model (XGBH) utilizing key contributing features significantly improves the accuracy of cardiovascular disease risk prediction compared to baseline risk scores, even when simplified to just three clinical variables.
Answers are grounded in this paper and cite their sources.
Machine learning models may improve CVD risk prediction accuracy; leaves open prospective validation before clinical adoption.
The risk of cardiovascular disease (CVD) is a serious health threat to human society worldwide. The use of machine learning methods to predict the risk of CVD is of great relevance to identify high-risk patients and take timely interventions. In this study, we propose the XGBH machine learning model, which is a CVD risk prediction model based on key contributing features. In this paper, the generalisation of the model was enhanced by adding retrospective data of 14,832 Chinese Shanxi CVD patients to the kaggle dataset. The XGBH risk prediction model proposed in this paper was validated to be highly accurate (AUC = 0.81) compared to the baseline risk score (AUC = 0.65), and the accuracy of the model for CVD risk prediction was improved with the inclusion of the conventional biometric BMI variable. To increase the clinical application of the model, a simpler diagnostic model was designed in this paper, which requires only three characteristics from the patient (age, value of systolic blood pressure and whether cholesterol is normal or not) to enable early intervention in the treatment of high-risk patients with a slight reduction in accuracy (AUC = 0.79). Ultimately, a CVD risk score model with few features and high accuracy will be established based on the main contributing features. Of course, further prospective studies, as well as studies with other populations, are needed to assess the actual clinical effectiveness of the XGBH risk prediction model.
No takes yet. Share an insight, caveat, or question.
Peng et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: